Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis
- PMID: 22521419
- PMCID: PMC3376540
- DOI: 10.1016/j.ajhg.2012.03.013
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis
Abstract
Psoriasis is a common inflammatory disorder of the skin and other organs. We have determined that mutations in CARD14, encoding a nuclear factor of kappa light chain enhancer in B cells (NF-kB) activator within skin epidermis, account for PSORS2. Here, we describe fifteen additional rare missense variants in CARD14, their distribution in seven psoriasis cohorts (>6,000 cases and >4,000 controls), and their effects on NF-kB activation and the transcriptome of keratinocytes. There were more CARD14 rare variants in cases than in controls (burden test p value = 0.0015). Some variants were only seen in a single case, and these included putative pathogenic mutations (c.424G>A [p.Glu142Lys] and c.425A>G [p.Glu142Gly]) and the generalized-pustular-psoriasis mutation, c.413A>C (p.Glu138Ala); these three mutations lie within the coiled-coil domain of CARD14. The c.349G>A (p.Gly117Ser) familial-psoriasis mutation was present at a frequency of 0.0005 in cases of European ancestry. CARD14 variants led to a range of NF-kB activities; in particular, putative pathogenic variants led to levels >2.5× higher than did wild-type CARD14. Two variants (c.511C>A [p.His171Asn] and c.536G>A [p.Arg179His]) required stimulation with tumor necrosis factor alpha (TNF-α) to achieve significant increases in NF-kB levels. Transcriptome profiling of wild-type and variant CARD14 transfectants in keratinocytes differentiated probably pathogenic mutations from neutral variants such as polymorphisms. Over 20 CARD14 polymorphisms were also genotyped, and meta-analysis revealed an association between psoriasis and rs11652075 (c.2458C>T [p.Arg820Trp]; p value = 2.1 × 10(-6)). In the two largest psoriasis cohorts, evidence for association increased when rs11652075 was conditioned on HLA-Cw*0602 (PSORS1). These studies contribute to our understanding of the genetic basis of psoriasis and illustrate the challenges faced in identifying pathogenic variants in common disease.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures




References
-
- Lowes M.A., Bowcock A.M., Krueger J.G. Pathogenesis and therapy of psoriasis. Nature. 2007;445:866–873. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AR050266/AR/NIAMS NIH HHS/United States
- T32 AR007279/AR/NIAMS NIH HHS/United States
- AR054966/AR/NIAMS NIH HHS/United States
- T32AR007279/AR/NIAMS NIH HHS/United States
- T32 HG000045/HG/NHGRI NIH HHS/United States
- T32HG000045/HG/NHGRI NIH HHS/United States
- T32 HL083822/HL/NHLBI NIH HHS/United States
- 5RC1AR058681/AR/NIAMS NIH HHS/United States
- R01 AR042742/AR/NIAMS NIH HHS/United States
- T32HL083822/HL/NHLBI NIH HHS/United States
- T32 GM07200/GM/NIGMS NIH HHS/United States
- CAPMC/ CIHR/Canada
- R01 AR054966/AR/NIAMS NIH HHS/United States
- R01 AR050511/AR/NIAMS NIH HHS/United States
- T32 GM007200/GM/NIGMS NIH HHS/United States
- AR060222/AR/NIAMS NIH HHS/United States
- R01 AR060222/AR/NIAMS NIH HHS/United States
- K08 AR057763/AR/NIAMS NIH HHS/United States
- RC1 AR058681/AR/NIAMS NIH HHS/United States
- K08AR057763/AR/NIAMS NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- R01 HD052973/HD/NICHD NIH HHS/United States
- AR050266/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials